CHEMOTHERAPY INDUCED ALOPECIA
Clinical trials for CHEMOTHERAPY INDUCED ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY INDUCED ALOPECIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY INDUCED ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cool cap showdown: which scalp cooling method best prevents chemo hair loss?
Symptom relief Recruiting nowThis study tests two ways to cool the scalp during chemotherapy to prevent hair loss in women with early-stage breast cancer. About 196 participants will receive either a standard cooling cap or a cooling mask while getting anthracycline and taxane chemotherapy. The goal is to se…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated May 26, 2026 03:59 UTC
-
Cool cap may keep hair during chemo for advanced breast cancer
Symptom relief Recruiting nowThis study tests if a special cooling cap can reduce hair loss in people with metastatic breast cancer who are receiving certain chemotherapy drugs. About 120 participants will either use the Paxman Scalp Cooling System or not, and researchers will compare hair loss rates and qua…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
New topical drug studied for chemo hair loss prevention
Knowledge-focused Recruiting nowThis early-phase trial is testing a topical phenylephrine solution in 24 healthy women aged 18-55 to see how much of the drug enters the bloodstream and how safe it is. The goal is to gather information that could help develop a treatment for chemotherapy-induced hair loss. Parti…
Matched conditions: CHEMOTHERAPY INDUCED ALOPECIA
Phase: EARLY_PHASE1 • Sponsor: Applied Biology, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC